Doctors, patients and researchers are at the very beginning of understanding how the new class of obesity drugs interact with ...
6don MSN
The rise of 'agonorexia': People are developing brand new eating disorders on GLP-1 agonist drugs
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...
Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold ...
In the United States, eating disorders are the second most deadly mental health issue (behind opioid use disorder). And they are more common than you may think, affecting about 9 percent of the U.S.
Editors’ Note: This article discusses suicide and contains details about mental health crises. If you are having thoughts of suicide, or are concerned that someone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results